Serum Institute kickstarts production of Covovax vaccine at Pune facility ahead of clinical trials on children

The Serum Institute of India (SII) on Friday announced that the world’s biggest vaccine manufacturer has commenced the production of the first batch of the new Covid-19 vaccine ‘Covovax’, developed by Novavax, at their facility in Pune. “A new milestone has been reached. This week we began our first batch of Covovax (a COVID-19 vaccine … Continue reading Serum Institute kickstarts production of Covovax vaccine at Pune facility ahead of clinical trials on children